LEADER 04657nam 22010813u 450 001 9910780301103321 005 20230607213857.0 010 $a0-309-50374-4 035 $a(CKB)111069351130742 035 $a(EBL)3375300 035 $a(SSID)ssj0000106797 035 $a(PQKBManifestationID)11138488 035 $a(PQKBTitleCode)TC0000106797 035 $a(PQKBWorkID)10132373 035 $a(PQKB)10978189 035 $a(MiAaPQ)EBC3375300 035 $a(EXLCZ)99111069351130742 100 $a20170301d2002|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAssessment of the CDC Anthrax vaccine safety and efficacy research program$b[electronic resource] 210 $aWashington $cNational Academies Press$d2002 215 $a1 online resource (179 p.) 300 $aDescription based upon print version of record. 311 $a0-309-08626-4 327 $a""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas"" 327 $a""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1"" 327 $a""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1"" 606 $aAnthrax -- Vaccination 606 $aPublic health 606 $aAnthrax$xVaccination$xResearch$zUnited States 606 $aBacterial Vaccines 606 $aEvaluation Studies as Topic 606 $aHealth Care Evaluation Mechanisms 606 $aQuality of Health Care 606 $aBacillaceae Infections 606 $aInvestigative Techniques 606 $aVaccines 606 $aHealth Services Administration 606 $aGram-Positive Bacterial Infections 606 $aBacterial Infections 606 $aHealth Care Quality, Access, and Evaluation 606 $aHealth Care 606 $aBiological Products 606 $aComplex Mixtures 606 $aBacterial Infections and Mycoses 606 $aDiseases 606 $aProgram Evaluation 606 $aDrug Evaluation 606 $aAnthrax 606 $aAnthrax Vaccines 606 $aPublic Health$2HILCC 606 $aHealth & Biological Sciences$2HILCC 606 $aCommunicable Diseases$2HILCC 615 4$aAnthrax -- Vaccination. 615 4$aPublic health. 615 0$aAnthrax$xVaccination$xResearch 615 2$aBacterial Vaccines 615 2$aEvaluation Studies as Topic 615 2$aHealth Care Evaluation Mechanisms 615 2$aQuality of Health Care 615 2$aBacillaceae Infections 615 2$aInvestigative Techniques 615 2$aVaccines 615 2$aHealth Services Administration 615 2$aGram-Positive Bacterial Infections 615 2$aBacterial Infections 615 2$aHealth Care Quality, Access, and Evaluation 615 2$aHealth Care 615 2$aBiological Products 615 2$aComplex Mixtures 615 2$aBacterial Infections and Mycoses 615 2$aDiseases 615 2$aProgram Evaluation 615 2$aDrug Evaluation 615 2$aAnthrax 615 2$aAnthrax Vaccines 615 7$aPublic Health 615 7$aHealth & Biological Sciences 615 7$aCommunicable Diseases 676 $a615 700 $aStaff$b Institute of Medicine$01462487 712 02$aInstitute of Medicine (U.S.) Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program. 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910780301103321 996 $aAssessment of the CDC Anthrax vaccine safety and efficacy research program$93671491 997 $aUNINA LEADER 02126oas 22007573a 450 001 9910225621903321 005 20251119213018.0 011 $a2332-9971 035 $a(OCoLC)50420718 035 $a(CONSER) 2013274122 035 $a(CKB)111030121295002 035 $a(EXLCZ)99111030121295002 100 $a20020816a20019999 sy a 101 0 $aeng 135 $aurunu---uuuuu 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aABA bank marketing 210 $aWashington, DC $cABA Marketing Network 300 $aTitle from ProQuest full text title list (viewed Aug. 16, 2002). 311 08$a1539-7890 517 3 $aAmerican Bankers Association bank marketing 517 3 $aBank marketing 606 $aBank marketing$zUnited States$vPeriodicals 606 $aBank management$zUnited States$vPeriodicals 606 $aBank management$2fast$3(OCoLC)fst00826723 606 $aBank marketing$2fast$3(OCoLC)fst00826746 606 $aBanques$xMarketing$zE?tats-Unis$vPe?riodiques 606 $aBanques$xGestion$zE?tats-Unis$vPe?riodiques 607 $aUnited States$2fast$1https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 608 $aWeb sites. 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aperiodicals.$2aat 608 $aPe?riodiques.$2rvmgf 615 0$aBank marketing 615 0$aBank management 615 7$aBank management. 615 7$aBank marketing. 615 6$aBanques$xMarketing 615 6$aBanques$xGestion 676 $a332.1/068/8 712 02$aABA Marketing Network 801 0$bBNG 801 1$bBNG 801 2$bOCLCQ 801 2$bTXJ 801 2$bCO3 801 2$bAD# 801 2$bOCLCE 801 2$bOCLCQ 801 2$bDLC 801 2$bCOO 801 2$bOCLCO 801 2$bOCLCF 801 2$bOCLCQ 801 2$bBWN 801 2$bDYJ 801 2$bOCLCQ 801 2$bOCLCL 801 2$bQGK 906 $aJOURNAL 912 $a9910225621903321 996 $aABA bank marketing$91979739 997 $aUNINA